4//SEC Filing
Repella Robert 4
Accession 0001209191-11-052629
CIK 0001347178other
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 4:34 PM ET
Size
8.1 KB
Accession
0001209191-11-052629
Insider Transaction Report
Form 4
Repella Robert
SVP & Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2011-10-24+60,000→ 60,000 total→ Common Stock (60,000 underlying) - Award
Employee Stock Option (Right to Buy)
2011-10-24+230,000→ 230,000 totalExercise: $5.90Exp: 2021-10-24→ Common Stock (230,000 underlying)
Footnotes (4)
- [F1]The option becomes exercisable with respect to 25% of the shares after 12 months of continuous service with the Issuer, with the balance becoming exercisable in equal monthly installments over the next 36 months of continuous service thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 1, 2013, provided that Mr. Repella has remained in continuous service with the Issuer on each applicable vesting date. The vested shares will be delivered to the Reporting Person upon vesting.
- [F4]Not applicable.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001532513
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 4:34 PM ET
- Size
- 8.1 KB